A detailed history of Neuberger Berman Group LLC transactions in Vericel Corp stock. As of the latest transaction made, Neuberger Berman Group LLC holds 6,242 shares of VCEL stock, worth $254,049. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,242
Previous 4,812 29.72%
Holding current value
$254,049
Previous $250,000 14.4%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$41.71 - $52.9 $59,645 - $75,647
1,430 Added 29.72%
6,242 $286,000
Q1 2024

May 13, 2024

BUY
$32.52 - $52.33 $156,486 - $251,811
4,812 New
4,812 $250,000
Q4 2023

Feb 09, 2024

BUY
$30.85 - $37.09 $179,115 - $215,344
5,806 New
5,806 $206,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $1.92B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.